<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC6958409\results\search\drug\results.xml">
  <result pre="the clinic are Matrix 2 (M2) ion channel inhibitors, (e.g.," exact="amantadine" post="and rimantadine) and neuraminidase (NA) inhibitors (e.g., oseltamivir and"/>
  <result pre="M2 and compared the efficacy of the novel compounds to" exact="amantadine" post="which led to new lead compounds against M2 [134,135]."/>
  <result pre="found to have a more severe phenotype than females. Importantly," exact="amantadine" post="was shown to rescue the M2 phenotype, suggesting Drosophila"/>
  <result pre="reactive oxygen species (ROS) and had increased expression of nicotinamide" exact="adenine" post="dinucleotide phosphate oxidases (Nox) [256]. One particular Nox that"/>
  <result pre="on NECs derived from male and female donors, showing that" exact="estrogen" post="exhibited protective effects upon infection in female, but not"/>
  <result pre="and ProtocolsJimenezG.SpringerNew York, NY, USA2017658810.1007/978-1-4939-6424-6_5 117.DeverT.E.ChenJ.J.BarberG.N.CiganA.M.FengL.DonahueT.F.LondonI.M.KatzeM.G.HinnebuschA.G.Mammalian eukaryotic initiation factor 2" exact="alpha" post="kinases functionally substitute for GCN2 protein kinase in the"/>
  <result pre="virus NS1 and Postsynaptic density protein-95 (PSD-95), and inhibition of" exact="nitric oxide" post="productionVirol. J.2011829810.1186/1743-422X-8-29821668967 152.WolffT.Oâ€™NeillR.E.PaleseP.Interaction cloning of NS1-I, a human protein"/>
 </snippets>
</snippetsTree>
